메뉴 건너뛰기




Volumn 24, Issue 2, 2011, Pages

Flutamide for Androgen Excess: Low Dose is Best

Author keywords

[No Author keywords available]

Indexed keywords

FLUTAMIDE;

EID: 79952079114     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpag.2010.02.005     Document Type: Letter
Times cited : (6)

References (8)
  • 1
    • 0029656166 scopus 로고    scopus 로고
    • Flutamide hepatotoxicity
    • Wysowski D.K., Fourcroy J.L. Flutamide hepatotoxicity. J Urol 1996, 155:209.
    • (1996) J Urol , vol.155 , pp. 209
    • Wysowski, D.K.1    Fourcroy, J.L.2
  • 2
    • 24344444078 scopus 로고    scopus 로고
    • Circulating antiandrogenic activity in children with congenital adrenal hyperplasia during peroral flutamide treatment
    • Hero M., Jänne O.A., Näntö-Salonen K., et al. Circulating antiandrogenic activity in children with congenital adrenal hyperplasia during peroral flutamide treatment. J Clin Endocrinol Metab 2005, 90:5141.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 5141
    • Hero, M.1    Jänne, O.A.2    Näntö-Salonen, K.3
  • 3
    • 0034031258 scopus 로고    scopus 로고
    • Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day)
    • Müderris, Bayram F., Güven M. Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day). Gynecol Endocrinol 2000, 14:38.
    • (2000) Gynecol Endocrinol , vol.14 , pp. 38
    • Müderris1    Bayram, F.2    Güven, M.3
  • 4
    • 34548799898 scopus 로고    scopus 로고
    • Spanish Working Group for Hirsutism: Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial
    • Calaf J., López E., Millet A., et al. Spanish Working Group for Hirsutism: Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial. J Clin Endocrinol Metab 2007, 92:3446.
    • (2007) J Clin Endocrinol Metab , vol.92 , pp. 3446
    • Calaf, J.1    López, E.2    Millet, A.3
  • 5
    • 4344566243 scopus 로고    scopus 로고
    • Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide
    • Ibáñez L., Valls C., Cabré S., et al. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide. J Clin Endocrinol Metab 2004, 89:4716.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 4716
    • Ibáñez, L.1    Valls, C.2    Cabré, S.3
  • 6
    • 68949204550 scopus 로고    scopus 로고
    • Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months
    • Ibáñez L., López-Bermejo A., Díaz M., et al. Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months. Clin Endocrinol 2009, 71:351.
    • (2009) Clin Endocrinol , vol.71 , pp. 351
    • Ibáñez, L.1    López-Bermejo, A.2    Díaz, M.3
  • 7
    • 64549090025 scopus 로고    scopus 로고
    • Low-dose flutamide for women with androgen excess: anti-androgenic efficacy and hepatic safety
    • de Zegher F., Ibáñez L. Low-dose flutamide for women with androgen excess: anti-androgenic efficacy and hepatic safety. J Endocrinol Invest 2009, 32:83.
    • (2009) J Endocrinol Invest , vol.32 , pp. 83
    • de Zegher, F.1    Ibáñez, L.2
  • 8
    • 64549127776 scopus 로고    scopus 로고
    • A comparison between finasteride, flutamide, and finasteride plus flutamide combination in the treatment of hirsutism
    • Unluhizarci K., Ozel D., Tanriverdi F., et al. A comparison between finasteride, flutamide, and finasteride plus flutamide combination in the treatment of hirsutism. J Endocrinol Invest 2009, 32:37.
    • (2009) J Endocrinol Invest , vol.32 , pp. 37
    • Unluhizarci, K.1    Ozel, D.2    Tanriverdi, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.